stockrowAssembly Biosciences, Inc. (ASMB) vs Gyre Therapeutics, Inc. (GYRE)
- Assembly Biosciences, Inc. ASMB 20.36 +1.80%
- Gyre Therapeutics, Inc. GYRE 4.72 +17.71%
Assembly Biosciences, Inc. and Gyre Therapeutics, Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and Gyre Therapeutics, Inc. are of similar size ($425.2M and $407.2M). Assembly Biosciences, Inc. grew revenue faster over the last twelve months: 125.1% against 13.5%. Assembly Biosciences, Inc. has the higher net margin (−0.06% vs −21.5%) and the higher return on invested capital (0.00% vs −8.51%). Across the 17 metrics below, Assembly Biosciences, Inc. leads on 11 and Gyre Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ASMB | GYRE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 91.71% | 68.51% |
| Operating margin | (11.75%) | 0.00% | 0.00% |
| Net margin | (0.06%) | (21.46%) | 0.00% |
| Free cash flow margin | (51.53%) | (19.94%) | 0.00% |
| Return on equity | (0.03%) | (18.54%) | (51.96%) |
| Return on assets | (0.02%) | (14.49%) | (46.06%) |
| Return on invested capital | 0.00% | (8.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack